The influence of gender on cardiac fibrosis induced by sympathetic stimulation

Yasutomo Hori1, Masami Uechi, Takashi Ebisawa

  • 1Department of Veterinary Medicine, School of Veterinary Medicine and Animal Science, Kitasato University, 23-35-1 Higashi, Towada, Aomori 034-8628, Japan.

Insights

Testosterone modulates cardiac responses to sympathetic agents like dobutamine and isoproterenol in mice. Sex steroids significantly impact cardiac fibrosis development, with testosterone playing a key role.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pharmacology

Background:

  • Sex steroids are known to influence various physiological processes.
  • The role of sex steroids in modulating the cardiovascular response to sympathetic stimulation requires further elucidation.
  • Understanding these interactions is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate the influence of sex steroids on the cardiac effects of sympathetic agents in mice.
  • To compare the cardiac response and fibrosis development between male, neutered male, female, and neutered female mice.
  • To determine the specific role of testosterone in modulating sympathetic nervous system effects on the heart.

Main Methods:

  • Mice were divided into four groups: males, neutered males (N-males), females, and neutered females (N-females).
  • Intravenous administration of dobutamine (DOB) and isoproterenol (ISO) to assess fractional shortening (FS).
  • Pathological evaluation of cardiac fibrosis using Azan stain after 3 weeks of isoproterenol administration.

Main Results:

  • Dobutamine and isoproterenol significantly increased fractional shortening in male mice compared to other groups.
  • No significant difference in fractional shortening was observed between female and neutered female groups.
  • Cardiac fibrosis was significantly higher in male mice compared to neutered males, and higher in both female groups compared to males.

Conclusions:

  • Testosterone appears to be a key factor in modulating the cardiovascular response to sympathetic nervous system stimulation.
  • Female sex steroids are associated with increased cardiac fibrosis, warranting further investigation.
  • These findings highlight the differential impact of sex steroids on cardiac function and pathology.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...